DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Finkel R, Chiriboga CA, Vajsar J. et al.
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.
Lancet 2016;
388: 3017-3026
doi:10.1016/S0140-6736(16)31408-8
We do not assume any responsibility for the contents of the web pages of other providers.